Trusted Perspectives in Clinical Research, Healthcare Policy & Biomedical Innovation
Recent CRISPR-based therapies show promise in treating genetic blood disorders such as sickle cell anemia and β-thalassemia. Clinical trials have reported up to 90% remission after single-dose treatments.
New brain-machine interfaces (BMIs) allow paralyzed patients to control digital devices with thought alone. Research from Stanford demonstrates typing speeds up to 90 characters per minute using neural decoding algorithms.
Growing evidence links gut microbiota composition with psychiatric outcomes. Fecal transplant studies suggest modulation of gut flora may alleviate symptoms in treatment-resistant depression.